Last reviewed · How we verify
Hypotonic fluid — Competitive Intelligence Brief
phase 3
Intravenous fluid therapy / Electrolyte solution
Critical Care / Fluid and Electrolyte Management
Small molecule
Live · refreshed every 30 min
Target snapshot
Hypotonic fluid (Hypotonic fluid) — All India Institute of Medical Sciences. Hypotonic fluid reduces serum osmolality by providing free water, promoting water movement into cells and reducing extracellular fluid volume.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Hypotonic fluid TARGET | Hypotonic fluid | All India Institute of Medical Sciences | phase 3 | Intravenous fluid therapy / Electrolyte solution |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Intravenous fluid therapy / Electrolyte solution class)
- All India Institute of Medical Sciences · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Hypotonic fluid CI watch — RSS
- Hypotonic fluid CI watch — Atom
- Hypotonic fluid CI watch — JSON
- Hypotonic fluid alone — RSS
- Whole Intravenous fluid therapy / Electrolyte solution class — RSS
Cite this brief
Drug Landscape (2026). Hypotonic fluid — Competitive Intelligence Brief. https://druglandscape.com/ci/hypotonic-fluid. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab